ACS Publications. Most Trusted. Most Cited. Most Read
Mitochondrial Targeting of Doxorubicin Eliminates Nuclear Effects Associated with Cardiotoxicity

OR SEARCH CITATIONS

My Activity
Publications

Figure 1Loading Img
Download Hi-Res ImageDownload to MS-PowerPointCite This:ACS Chem. Biol. 2015, 10, 9, 2007-2015
    Articles

    Mitochondrial Targeting of Doxorubicin Eliminates Nuclear Effects Associated with Cardiotoxicity
    Click to copy article linkArticle link copied!

    View Author Information
    † †Department of Chemistry, Faculty of Arts and Science, University of Toronto, Toronto, Ontario M5S 3H6, Canada
    ‡ ‡Department of Biochemistry, University of Toronto, Toronto, Ontario M5S 1A8, Canada
    § §Department of Medical Biophysics, Faculty of Medicine, University of Toronto, Toronto, Ontario M5G 1L7, Canada
    ∥ ∥Princess Margaret Cancer Center, University Health Network, Toronto, Ontario M5G 2M9, Canada
    ⊥ Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario M5S 3M2, Canada
    ⊗ Department of Oncology, University of Torino, via Santena 5/bis, 10126 Torino, Italy
    *E-mail: [email protected]
    Other Access OptionsSupporting Information (1)

    ACS Chemical Biology

    Cite this: ACS Chem. Biol. 2015, 10, 9, 2007–2015
    Click to copy citationCitation copied!
    https://doi.org/10.1021/acschembio.5b00268
    Published June 3, 2015
    Copyright © 2015 American Chemical Society
    Request reuse permissions

    Abstract

    Click to copy section linkSection link copied!
    Abstract Image

    The highly effective anticancer agent doxorubicin (Dox) is a frontline drug used to treat a number of cancers. While Dox has a high level of activity against cancer cells, its clinical use is often complicated by dose-limiting cardiotoxicity. While this side effect has been linked to the drug’s direct activity in the mitochondria of cardiac cells, recent studies have shown that these result primarily from downstream effects of nuclear DNA damage. Our lab has developed a mitochondrially targeted derivative of Dox that enables the selective study of toxicity generated by the presence of Dox in the mitochondria of human cells. We demonstrate that mitochondria-targeted doxorubicin (mtDox) lacks any direct nuclear effects in H9c2 rat cardiomyocytes, and that these cells are able to undergo mitochondrial biogenesis. This recovery response compensates for the mitotoxic effects of Dox and prevents cell death in cardiomyocytes. Furthermore, cardiac toxicity was only observed in Dox but not mtDox treated mice. This study supports the hypothesis that mitochondrial damage is not the main source of the cardiotoxic effects of Dox.

    Copyright © 2015 American Chemical Society

    Subjects

    what are subjects

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.

    Recommended

    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. Add or change your institution or let them know you’d like them to include access.

    Supporting Information

    Click to copy section linkSection link copied!

    Additional figures and tables. The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acschembio.5b00268.

    Terms & Conditions

    Electronic Supporting Information files are available without a subscription to ACS Web Editions. The American Chemical Society holds a copyright ownership interest in any copyrightable Supporting Information. Files available from the ACS website may be downloaded for personal use only. Users are not otherwise permitted to reproduce, republish, redistribute, or sell any Supporting Information from the ACS website, either in whole or in part, in either machine-readable form or any other form without permission from the American Chemical Society. For permission to reproduce, republish and redistribute this material, requesters must process their own requests via the RightsLink permission system. Information about how to use the RightsLink permission system can be found at http://pubs.acs.org/page/copyright/permissions.html.

    Cited By

    Click to copy section linkSection link copied!
    Citation Statements
    Explore this article's citation statements on scite.ai
    powered by  Scite

    This article is cited by 65 publications.

    1. Tanja Sack, Piriththiv Dhavarasa, Daniel Szames, Siobhan O’Brien, Stephane Angers, Shana O. Kelley. CRISPR Screening in Tandem with Targeted mtDNA Damage Reveals WRNIP1 Essentiality. ACS Chemical Biology 2023, 18 (12) , 2599-2609. https://doi.org/10.1021/acschembio.3c00620
    2. Cindy Ma, Fan Xia, Shana O. Kelley. Mitochondrial Targeting of Probes and Therapeutics to the Powerhouse of the Cell. Bioconjugate Chemistry 2020, 31 (12) , 2650-2667. https://doi.org/10.1021/acs.bioconjchem.0c00470
    3. Jyothi B. Nair, Manu M. Joseph, Jayadev S. Arya, Padincharapad Sreedevi, Palasseri T. Sujai, Kaustabh Kumar Maiti. Elucidating a Thermoresponsive Multimodal Photo-Chemotherapeutic Nanodelivery Vehicle to Overcome the Barriers of Doxorubicin Therapy. ACS Applied Materials & Interfaces 2020, 12 (39) , 43365-43379. https://doi.org/10.1021/acsami.0c08762
    4. Soyoung Kim, Ho Yeon Nam, Jiyoun Lee, Jiwon Seo. Mitochondrion-Targeting Peptides and Peptidomimetics: Recent Progress and Design Principles. Biochemistry 2020, 59 (3) , 270-284. https://doi.org/10.1021/acs.biochem.9b00857
    5. Upashi Goswami, Raghuram Kandimalla, Sanjeeb Kalita, Arun Chattopadhyay, Siddhartha Sankar Ghosh. Polyethylene Glycol-Encapsulated Histone Deacetylase Inhibitor Drug-Composite Nanoparticles for Combination Therapy with Artesunate. ACS Omega 2018, 3 (9) , 11504-11516. https://doi.org/10.1021/acsomega.8b02105
    6. Abhik Mallick, Meenu Mahesh Kuman, Arijit Ghosh, Benu Brata Das, Sudipta Basu. Cerberus Nanoparticles: Cotargeting of Mitochondrial DNA and Mitochondrial Topoisomerase I in Breast Cancer Cells. ACS Applied Nano Materials 2018, 1 (5) , 2195-2205. https://doi.org/10.1021/acsanm.8b00279
    7. Eric K. Lei and Shana O. Kelley . Delivery and Release of Small-Molecule Probes in Mitochondria Using Traceless Linkers. Journal of the American Chemical Society 2017, 139 (28) , 9455-9458. https://doi.org/10.1021/jacs.7b04415
    8. Sae Rin Jean, Marya Ahmed, Eric K. Lei, Simon P. Wisnovsky, and Shana O. Kelley . Peptide-Mediated Delivery of Chemical Probes and Therapeutics to Mitochondria. Accounts of Chemical Research 2016, 49 (9) , 1893-1902. https://doi.org/10.1021/acs.accounts.6b00277
    9. Yingjie Fu, Qishuai Feng, Yifan Chen, Yajing Shen, Qihang Su, Yinglei Zhang, Xiang Zhou, and Yu Cheng . Comparison of Two Approaches for the Attachment of a Drug to Gold Nanoparticles and Their Anticancer Activities. Molecular Pharmaceutics 2016, 13 (9) , 3308-3317. https://doi.org/10.1021/acs.molpharmaceut.6b00619
    10. Konstantin Chegaev, Barbara Rolando, Daniela Cortese, Elena Gazzano, Ilaria Buondonno, Loretta Lazzarato, Marilù Fanelli, Claudia M. Hattinger, Massimo Serra, Chiara Riganti, Roberta Fruttero, Dario Ghigo, and Alberto Gasco . H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance. Journal of Medicinal Chemistry 2016, 59 (10) , 4881-4889. https://doi.org/10.1021/acs.jmedchem.6b00184
    11. Roberto Arrigoni, Emilio Jirillo, Carlo Caiati. Pathophysiology of Doxorubicin-Mediated Cardiotoxicity. Toxics 2025, 13 (4) , 277. https://doi.org/10.3390/toxics13040277
    12. . Gold Complexes as Anticancer Agents. 2025, 15-38. https://doi.org/10.1039/9781837678891-00015
    13. Zufeng Zhang, Weiwei Zhou, Yuxin Zhang, Yuanyuan Hu, Junyu Mou, Xuefeng Wang, Ling Liu, Wei Zheng. Advances for anti-inflammatory ingredients and activities of Fuzi (lateral root of Aconitum carmichaelii Debx.). International Journal of Food Properties 2024, 27 (1) , 53-70. https://doi.org/10.1080/10942912.2023.2293461
    14. Jhong‐Kuei Chen, Samiraj Ramesh, Md. Nazmul Islam, Marthandam Asokan Shibu, Chia‐Hua Kuo, Dennis Jine‐Yuan Hsieh, Shinn‐Zong Lin, Wei‐Wen Kuo, Chih‐Yang Huang, Tsung‐Jung Ho. Ohwia caudata inhibits doxorubicin‐induced cardiotoxicity by regulating mitochondrial dynamics via the IGF‐IIR/p‐Drp1/PARP signaling pathway. Biotechnology and Applied Biochemistry 2024, 71 (5) , 1181-1194. https://doi.org/10.1002/bab.2620
    15. Aysegul Ekmekcioglu, Ozgul Gok, Devrim Oz-Arslan, Meryem Sedef Erdal, Yasemin Yagan Uzuner, Meltem Muftuoglu. Mitochondria-Targeted Liposomes for Drug Delivery to Tumor Mitochondria. Pharmaceutics 2024, 16 (7) , 950. https://doi.org/10.3390/pharmaceutics16070950
    16. Zhong-Na Zhang, Si-Han Yin, Xue Li, Yu-Yao Wang, Kun Zhang, Jing-An Li. Research and Application of Metal–Organic Framework in Surface Modification of Biomaterials—A Review. Metals 2023, 13 (9) , 1511. https://doi.org/10.3390/met13091511
    17. Hamid Aria, Marzieh Rezaei. Immunogenic cell death inducer peptides: A new approach for cancer therapy, current status and future perspectives. Biomedicine & Pharmacotherapy 2023, 161 , 114503. https://doi.org/10.1016/j.biopha.2023.114503
    18. Tamalika Sanyal, Ankita Das, Priya Bhowmick, Pritha Bhattacharjee. Interplay between environmental exposure and mitochondrial DNA methylation in disease susceptibility and cancer: a comprehensive review. The Nucleus 2023, 66 (1) , 53-68. https://doi.org/10.1007/s13237-022-00392-5
    19. Dmitry A. Veryutin, Irina A. Doroshenko, Ekaterina A. Martynova, Ksenia A. Sapozhnikova, Elena V. Svirshchevskaya, Anna V. Shibaeva, Alina A. Markova, Alexey A. Chistov, Natalya E. Borisova, Maxim V. Shuvalov, Vladimir A. Korshun, Vera A. Alferova, Tatyana A. Podrugina. Probing tricarbocyanine dyes for targeted delivery of anthracyclines. Biochimie 2023, 206 , 12-23. https://doi.org/10.1016/j.biochi.2022.09.015
    20. Subramaniyam Sivagnanam, Kiran Das, Vijay Sivakadatcham, Tarun Mahata, Madhuri Basak, Ieshita Pan, Adele Stewart, Biswanath Maity, Priyadip Das. Generation of Self‐Assembled Structures Composed of Amphipathic, Charged Tripeptides for Intracellular Delivery of Pro‐Apoptotic Chemotherapeutics. Israel Journal of Chemistry 2022, 62 (9-10) https://doi.org/10.1002/ijch.202200001
    21. Sumia Ehsan, Obdulia Covarrubias-Zambrano, Stefan H. Bossmann. Mitochondrial Targeting Peptide-based Nanodelivery for Cancer Treatment. Current Protein & Peptide Science 2022, 23 (10) , 657-671. https://doi.org/10.2174/1389203723666220520160435
    22. Yingying Shi, Zhenyu Luo, Jian You. Subcellular delivery of lipid nanoparticles to endoplasmic reticulum and mitochondria. WIREs Nanomedicine and Nanobiotechnology 2022, 14 (5) https://doi.org/10.1002/wnan.1803
    23. Xiaoli Tang, Zengwu Wang, Shengshou Hu, Bingying Zhou. Assessing Drug-Induced Mitochondrial Toxicity in Cardiomyocytes: Implications for Preclinical Cardiac Safety Evaluation. Pharmaceutics 2022, 14 (7) , 1313. https://doi.org/10.3390/pharmaceutics14071313
    24. Humayra Afrin, Christiancel Joseph Salazar, Mohsin Kazi, Syed Rizwan Ahamad, Majed Alharbi, Md Nurunnabi. Methods of screening, monitoring and management of cardiac toxicity induced by chemotherapeutics. Chinese Chemical Letters 2022, 33 (6) , 2773-2782. https://doi.org/10.1016/j.cclet.2022.01.011
    25. Sukhvir Kaur Bhangu, Soraia Fernandes, Giovanni Luca Beretta, Stella Tinelli, Marco Cassani, Agata Radziwon, Marcin Wojnilowicz, Sophia Sarpaki, Irinaios Pilatis, Nadia Zaffaroni, Giancarlo Forte, Frank Caruso, Muthupandian Ashokkumar, Francesca Cavalieri. Transforming the Chemical Structure and Bio‐Nano Activity of Doxorubicin by Ultrasound for Selective Killing of Cancer Cells. Advanced Materials 2022, 34 (13) https://doi.org/10.1002/adma.202107964
    26. Haneul Cho, Xiao-Xiao Zhao, Sora Lee, Jong Shin Woo, Min-Young Song, Xian Wu Cheng, Kyung Hye Lee, Weon Kim. The sGC-cGMP Signaling Pathway as a Potential Therapeutic Target in Doxorubicin-Induced Heart Failure: A Narrative Review. American Journal of Cardiovascular Drugs 2022, 22 (2) , 117-125. https://doi.org/10.1007/s40256-021-00487-5
    27. Shah Alam Khan, Md Jawaid Akhtar. Structural modification and strategies for the enhanced doxorubicin drug delivery. Bioorganic Chemistry 2022, 120 , 105599. https://doi.org/10.1016/j.bioorg.2022.105599
    28. Claudia Maria Hattinger, Maria Pia Patrizio, Leonardo Fantoni, Chiara Casotti, Chiara Riganti, Massimo Serra. Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies. Cancers 2021, 13 (12) , 2878. https://doi.org/10.3390/cancers13122878
    29. Federica Guarra, Alessandro Pratesi, Chiara Gabbiani, Tarita Biver. A focus on the biological targets for coinage metal-NHCs as potential anticancer complexes. Journal of Inorganic Biochemistry 2021, 217 , 111355. https://doi.org/10.1016/j.jinorgbio.2021.111355
    30. Pelin A. Golforoush, Priyanka Narasimhan, Patricia P. Chaves-Guerrero, Elsa Lawrence, Gary Newton, Robert Yan, Sian E. Harding, Trevor Perrior, Kathryn L. Chapman, Michael D. Schneider. Selective protection of human cardiomyocytes from anthracycline cardiotoxicity by small molecule inhibitors of MAP4K4. Scientific Reports 2020, 10 (1) https://doi.org/10.1038/s41598-020-68907-1
    31. Ram Pada Das, Beena Gobind Singh, Amit Kunwar. Preparation of a size selective nanocomposite through temperature assisted co-assembly of gelatin and pluronic F127 for passive targeting of doxorubicin. Biomaterials Science 2020, 8 (15) , 4251-4265. https://doi.org/10.1039/D0BM00725K
    32. Keith Dadson, Oscar Calvillo-Argüelles, Paaladinesh Thavendiranathan, Filio Billia. Anthracycline-induced cardiomyopathy: cellular and molecular mechanisms. Clinical Science 2020, 134 (13) , 1859-1885. https://doi.org/10.1042/CS20190653
    33. Xi Chu, Yuanyuan Zhang, Yucong Xue, Ziliang Li, Jing Shi, Hongfang Wang, Li Chu. Crocin protects against cardiotoxicity induced by doxorubicin through TLR-2/NF-κB signal pathway in vivo and vitro. International Immunopharmacology 2020, 84 , 106548. https://doi.org/10.1016/j.intimp.2020.106548
    34. Valentina Sala, Angela Della Sala, Emilio Hirsch, Alessandra Ghigo. Signaling Pathways Underlying Anthracycline Cardiotoxicity. Antioxidants & Redox Signaling 2020, 32 (15) , 1098-1114. https://doi.org/10.1089/ars.2020.8019
    35. Kendall B. Wallace, Vilma A. Sardão, Paulo J. Oliveira. Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy. Circulation Research 2020, 126 (7) , 926-941. https://doi.org/10.1161/CIRCRESAHA.119.314681
    36. Xiaoxue Yu, Yang Ruan, Xiuqing Huang, Lin Dou, Ming Lan, Ju Cui, Beidong Chen, Huan Gong, Que Wang, Mingjing Yan, Shenghui Sun, Quan Qiu, Xiyue Zhang, Yong Man, Weiqing Tang, Jian Li, Tao Shen. Dexrazoxane ameliorates doxorubicin-induced cardiotoxicity by inhibiting both apoptosis and necroptosis in cardiomyocytes. Biochemical and Biophysical Research Communications 2020, 523 (1) , 140-146. https://doi.org/10.1016/j.bbrc.2019.12.027
    37. Yuma Yamada, Satrialdi, Mitsue Hibino, Daisuke Sasaki, Jiro Abe, Hideyoshi Harashima. Power of mitochondrial drug delivery systems to produce innovative nanomedicines. Advanced Drug Delivery Reviews 2020, 154-155 , 187-209. https://doi.org/10.1016/j.addr.2020.09.010
    38. M.T. Jeena, Sangpil Kim, Seongeon Jin, Ja-Hyoung Ryu. Recent Progress in Mitochondria-Targeted Drug and Drug-Free Agents for Cancer Therapy. Cancers 2020, 12 (1) , 4. https://doi.org/10.3390/cancers12010004
    39. Xiaoyan Tan, Yanlin Zhou, Li Shen, Han Jia, Xiaorong Tan. A mitochondria-targeted delivery system of doxorubicin and evodiamine for the treatment of metastatic breast cancer. RSC Advances 2019, 9 (63) , 37067-37078. https://doi.org/10.1039/C9RA07096F
    40. Lucia Biasutto, Andrea Mattarei, Martina La Spina, Michele Azzolini, Sofia Parrasia, Ildikò Szabò, Mario Zoratti. Strategies to target bioactive molecules to subcellular compartments. Focus on natural compounds. European Journal of Medicinal Chemistry 2019, 181 , 111557. https://doi.org/10.1016/j.ejmech.2019.07.060
    41. Ting Xue, Caina Xu, Yu Wang, Yanbing Wang, Huayu Tian, Yingchao Zhang. Doxorubicin-loaded nanoscale metal–organic framework for tumor-targeting combined chemotherapy and chemodynamic therapy. Biomaterials Science 2019, 7 (11) , 4615-4623. https://doi.org/10.1039/C9BM01044K
    42. Simone A Baechler, Ilaria Dalla Rosa, Antonella Spinazzola, Yves Pommier. Beyond the unwinding: role of TOP1MT in mitochondrial translation. Cell Cycle 2019, 18 (19) , 2377-2384. https://doi.org/10.1080/15384101.2019.1646563
    43. Mandeep Atwal, Rebecca L. Swan, Chloe Rowe, Ka C. Lee, David C. Lee, Lyle Armstrong, Ian G. Cowell, Caroline A. Austin. Intercalating TOP2 Poisons Attenuate Topoisomerase Action at Higher Concentrations. Molecular Pharmacology 2019, 96 (4) , 475-484. https://doi.org/10.1124/mol.119.117259
    44. Sajal Sen, Yue Li, Vincent Lynch, Kuppuswamy Arumugam, Jonathan L. Sessler, Jonathan F. Arambula. Expanding the biological utility of bis-NHC gold( i ) complexes through post synthetic carbamate conjugation. Chemical Communications 2019, 55 (71) , 10627-10630. https://doi.org/10.1039/C9CC05635A
    45. Petro P. Czupiel, Vianney Delplace, Molly S. Shoichet. Cationic block amphiphiles show anti-mitochondrial activity in multi-drug resistant breast cancer cells. Journal of Controlled Release 2019, 305 , 210-219. https://doi.org/10.1016/j.jconrel.2019.04.045
    46. Yanan Tan, Xiqin Yang, Suhuan Dai, Keke Lian, Lijuan Wen, Yun Zhu, Tingting Meng, Xuan Liu, Hong Yuan, Fuqiang Hu. In vivo programming of tumor mitochondria-specific doxorubicin delivery by a cationic glycolipid polymer for enhanced antitumor activity. Polymer Chemistry 2019, 10 (4) , 512-525. https://doi.org/10.1039/C8PY01504J
    47. Hui Sun, Zhongyi Tong, Yeqing Fang, Bimei Jiang, Pengfei Liang, Yuting Tang, Yuanbin Li, Yanyang Wu, Xianzhong Xiao. Nucleolin protects against doxorubicin‐induced cardiotoxicity via upregulating microRNA‐21. Journal of Cellular Physiology 2018, 233 (12) , 9516-9525. https://doi.org/10.1002/jcp.26854
    48. Canan G. Nebigil, Laurent Désaubry. Updates in Anthracycline-Mediated Cardiotoxicity. Frontiers in Pharmacology 2018, 9 https://doi.org/10.3389/fphar.2018.01262
    49. Roberto Marques Damiani, Dinara Jaqueline Moura, Cassiana Macagnan Viau, Verônica Brito, Ana Moira Morás, João Antonio Pêgas Henriques, Jenifer Saffi. Influence of PARP-1 inhibition in the cardiotoxicity of the topoisomerase 2 inhibitors doxorubicin and mitoxantrone. Toxicology in Vitro 2018, 52 , 203-213. https://doi.org/10.1016/j.tiv.2018.06.013
    50. Mengmeng Luo, Qing Li, Dongmei Wang, Chaoxiang Ge, Jingjie Wang, Kaihui Nan, Sen Lin. Fabrication of chitosan based nanocomposite with legumain sensitive properties using charge driven self-assembly strategy. Journal of Materials Science: Materials in Medicine 2018, 29 (9) https://doi.org/10.1007/s10856-018-6149-y
    51. Celal Guven, Yusuf Sevgiler, Eylem Taskin. Mitochondrial Dysfunction Associated with Doxorubicin. 2018https://doi.org/10.5772/intechopen.80284
    52. Elena Gazzano, Loretta Lazzarato, Barbara Rolando, Joanna Kopecka, Stefano Guglielmo, Costanzo Costamagna, Konstantin Chegaev, Chiara Riganti. Mitochondrial Delivery of Phenol Substructure Triggers Mitochondrial Depolarization and Apoptosis of Cancer Cells. Frontiers in Pharmacology 2018, 9 https://doi.org/10.3389/fphar.2018.00580
    53. Yi Wang, Guoqing Wei, Xiaobin Zhang, Xuehui Huang, Jingya Zhao, Xing Guo, Shaobing Zhou. Multistage Targeting Strategy Using Magnetic Composite Nanoparticles for Synergism of Photothermal Therapy and Chemotherapy. Small 2018, 14 (12) https://doi.org/10.1002/smll.201702994
    54. Dana M. Copolovici, Andreea I. Lupitu. Peptide-based systems for drug delivery. 2018, 409-429. https://doi.org/10.1016/B978-0-08-100736-5.00017-X
    55. Kaviyarasi Renu, Abilash V.G., Tirupathi Pichiah P.B., Sankarganesh Arunachalam. Molecular mechanism of doxorubicin-induced cardiomyopathy – An update. European Journal of Pharmacology 2018, 818 , 241-253. https://doi.org/10.1016/j.ejphar.2017.10.043
    56. Christian Henninger, Gerhard Fritz. Statins in anthracycline-induced cardiotoxicity: Rac and Rho, and the heartbreakers. Cell Death & Disease 2018, 8 (1) , e2564-e2564. https://doi.org/10.1038/cddis.2016.418
    57. Katerina Panagiotaki, Zili Sideratou, Spiros Vlahopoulos, Maria Paravatou-Petsotas, Michael Zachariadis, Nikolas Khoury, Vassilis Zoumpourlis, Dimitris Tsiourvas. A Triphenylphosphonium-Functionalized Mitochondriotropic Nanocarrier for Efficient Co-Delivery of Doxorubicin and Chloroquine and Enhanced Antineoplastic Activity. Pharmaceuticals 2017, 10 (4) , 91. https://doi.org/10.3390/ph10040091
    58. Yunok Oh, Jun-O Jin, Junghwan Oh. Photothermal-triggered control of sub-cellular drug accumulation using doxorubicin-loaded single-walled carbon nanotubes for the effective killing of human breast cancer cells. Nanotechnology 2017, 28 (12) , 125101. https://doi.org/10.1088/1361-6528/aa5d7d
    59. Yeon Su Choi, Kiyoon Kwon, Kwonhyeok Yoon, Kang Moo Huh, Han Chang Kang. Photosensitizer-mediated mitochondria-targeting nanosized drug carriers: Subcellular targeting, therapeutic, and imaging potentials. International Journal of Pharmaceutics 2017, 520 (1-2) , 195-206. https://doi.org/10.1016/j.ijpharm.2017.02.013
    60. Jordan J. Bartlett, Purvi C. Trivedi, Thomas Pulinilkunnil. Autophagic dysregulation in doxorubicin cardiomyopathy. Journal of Molecular and Cellular Cardiology 2017, 104 , 1-8. https://doi.org/10.1016/j.yjmcc.2017.01.007
    61. Roxana Y. P. Alta, Hector A. Vitorino, Dibakar Goswami, Cleber W. Liria, Simon P. Wisnovsky, Shana O. Kelley, M. Terêsa Machini, Breno P. Espósito, . Mitochondria-penetrating peptides conjugated to desferrioxamine as chelators for mitochondrial labile iron. PLOS ONE 2017, 12 (2) , e0171729. https://doi.org/10.1371/journal.pone.0171729
    62. Ying Ji, Shuo Shan, Mingyu He, Chih-Chang Chu. A Novel Pseudo-Protein-Based Biodegradable Nanomicellar Platform for the Delivery of Anticancer Drugs. Small 2017, 13 (1) , 1601491. https://doi.org/10.1002/smll.201601491
    63. Ilaria Buondonno, Elena Gazzano, Sae Rin Jean, Valentina Audrito, Joanna Kopecka, Marilù Fanelli, Iris C. Salaroglio, Costanzo Costamagna, Ilaria Roato, Eleonora Mungo, Claudia M. Hattinger, Silvia Deaglio, Shana O. Kelley, Massimo Serra, Chiara Riganti. Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma. Molecular Cancer Therapeutics 2016, 15 (11) , 2640-2652. https://doi.org/10.1158/1535-7163.MCT-16-0048
    64. Simon Wisnovsky, Eric K. Lei, Sae Rin Jean, Shana O. Kelley. Mitochondrial Chemical Biology: New Probes Elucidate the Secrets of the Powerhouse of the Cell. Cell Chemical Biology 2016, 23 (8) , 917-927. https://doi.org/10.1016/j.chembiol.2016.06.012
    65. Dennis Curry, Amanda Cameron, Bruce MacDonald, Collins Nganou, Hope Scheller, James Marsh, Stefanie Beale, Mingsheng Lu, Zhi Shan, Rajendran Kaliaperumal, Heping Xu, Mark Servos, Craig Bennett, Stephanie MacQuarrie, Ken D. Oakes, Martin Mkandawire, Xu Zhang. Adsorption of doxorubicin on citrate-capped gold nanoparticles: insights into engineering potent chemotherapeutic delivery systems. Nanoscale 2015, 7 (46) , 19611-19619. https://doi.org/10.1039/C5NR05826K
    Download PDF
    Go to ACS Chemical Biology
    Get e-Alerts
    Get e-Alerts

    ACS Chemical Biology

    Cite this: ACS Chem. Biol. 2015, 10, 9, 2007–2015
    Click to copy citationCitation copied!
    https://doi.org/10.1021/acschembio.5b00268
    Published June 3, 2015
    Copyright © 2015 American Chemical Society
    Request reuse permissions

    Article Views

    2823

    Altmetric

    -

    Citations

    65
    Learn about these metrics

    Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.

    Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.

    The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.